- Clinical Trials
- August 2024
- 70 Pages
Global
From €3066EUR$3,450USD£2,654GBP
- Clinical Trials
- August 2024
- 529 Pages
Global
From €3066EUR$3,450USD£2,654GBP
- Report
- August 2024
- 63 Pages
Global
From €3105EUR$3,495USD£2,689GBP
- Report
- August 2024
- 66 Pages
Global
From €3105EUR$3,495USD£2,689GBP
- Report
- August 2024
- 76 Pages
Global
From €3105EUR$3,495USD£2,689GBP
- Report
- August 2024
- 79 Pages
Global
From €3105EUR$3,495USD£2,689GBP
- Report
- August 2024
- 18 Pages
Global
From €13324EUR$14,995USD£11,537GBP
- Report
- August 2024
- 121 Pages
Global
From €13324EUR$14,995USD£11,537GBP
- Report
- August 2025
- 142 Pages
Global
From €5198EUR$5,850USD£4,501GBP
- Report
- August 2025
- 331 Pages
Global
From €5198EUR$5,850USD£4,501GBP
- Report
- August 2025
- 246 Pages
Global
From €5198EUR$5,850USD£4,501GBP
- Report
- June 2025
- 400 Pages
Global
From €4397EUR$4,949USD£3,808GBP
- Report
- June 2025
- 150 Pages
Global
From €2398EUR$2,699USD£2,077GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2478EUR$2,789USD£2,146GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2478EUR$2,789USD£2,146GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2478EUR$2,789USD£2,146GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2478EUR$2,789USD£2,146GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2478EUR$2,789USD£2,146GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2478EUR$2,789USD£2,146GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2478EUR$2,789USD£2,146GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more